Cresco Labs Approved to Open First Ohio Medical Cannabis Dispensary

Visit the Cresco Labs Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Cresco Labs to Transform the Medical Marijuana Industry in Ohio

Granted Approval to Open the State’s First Medical Marijuana Dispensary

WINTERSVILLE, Ohio, December 12, 2018 –(BUSINESS WIRE)–Cresco Labs (CSE:CL), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it has been granted the first approval to operate a marijuana dispensary in the state of Ohio. The new facility located in the village of Wintersville, named CY+ (pronounced “see why plus”), will offer a wide selection of pharmaceutical-grade cannabis for physician-certified patients across Ohio.

Receiving the first approval to operate is a major milestone in the transformation of the cannabis program in Ohio. This is also a big step forward for Cresco along our path of unparalleled speed to market, powerful influence in industry development, and proven execution in consumer markets.

Charles Bachtell, CEO of Cresco Labs

The CY+ dispensary will offer a full selection of premium-quality medical marijuana for patients who have been physician-certified to have any one of 21 approved medical conditions. In addition to the dispensary in Wintersville, Cresco Labs has built an environmentally-advanced 50,000 square foot growing and cultivation facility in Yellow Springs, Ohio which will supply statewide dispensaries with Cresco’s full suite of branded products.

“At Cresco, we pride ourselves on understanding the individual needs of each and every one of our patients. Our Wintersville staff is trained by leading cannabis doctors and researchers across the country to ensure that our patients’ specific needs are consistently met. In Wintersville we will continue to advance our mission of normalizing and professionalizing the cannabis industry for consumers,” Bachtell added.

The Wintersville dispensary features private, one-on-one consultation areas where patients can feel comfortable discussing their conditions or symptoms and exploring the appropriate medical marijuana products. Products offered will range from edibles, vape pens and cartridges to oral sprays, pills, and transdermal patches. Video footage of the new dispensary can be downloaded and viewed here.

About Cresco Labs:

Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.

Original press release

For fact-based information on Cresco Labs, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter